Nuclear Medicine & Radiation Therapy

Department of Physics, University of Oxford, United Kingdom

Publications

• Research Article   
  A Prospective Study on Chemotherapy Induced Anemia Using Serial Hemoglobin Measurement in Cancer Patients Undergoing Treatment at National Hospital Abuja, Nigeria
  Author(s): Simeon C Aruah*, Rasaq Oyesegun and Laurence Wroe
  
  Objectives: Anemia is a common complication of myelo-suppressive chemotherapy. Severe anemia is treated with red blood cell transfusion. Mild-to-moderate anemia are managed conservatively. There is no established benchmark for hemoglobin of patients to guide a global best practice and enhance treatment outcome. This study examines the change in Hb levels of cancer patients undergoing chemotherapy measuring Hb after treatment. Methods: About 100 voluntary patients with solid malignancies were recruited within 8 months. Baseline demographic characteristics and tumours types were documented. Pre-treatment Hb level was measured on the first day of consultation and repeated every 2 weeks during and after the therapy until after three consecutive Hb readings. Results: Breast 68% (68) was the commonest site of tumor. Prev.. Read More»
  DOI: 10.37421/2155-9619.2021.12.426

  Abstract HTML PDF